Stem Cell Therapy Market Research, 2031
The global stem cell therapy market was valued at $205.1 million in 2021, and is projected to reach $928.6 million by 2031, growing at a CAGR of 16.2% from 2022 to 2031. Stem cells are the body's raw materials that are the cells from which all other cells with specialized functions are generated. Stem cell therapy which is also known as regenerative medicine promotes the repair response of diseased, dysfunctional or injured tissue using stem cells or its derivatives. It is the further step in organ transplantation and uses cells instead of donor organs, which are limited in supply. Researchers grow stem cells in a laboratory. These stem cells are manipulated to specialize into specific types of cells, such as heart muscle cells, blood cells or nerve cells. The cells further can be implanted into a person. For instance, if the person has heart disease, the cells could be injected into the heart muscle. The healthy transplanted heart muscle cells could then contribute to repairing the injured heart muscle. In the process of stem cell transplantation, the stem cells are replaced with damaged cells by chemotherapy or serve as a way for the donor's immune system to fight some types of cancer and blood-related diseases, such as leukemia, lymphoma, neuroblastoma and multiple myeloma. These transplants use adult stem cells or umbilical cord blood.
The growth of the stem cell therapy market size is driven by increase in demand for stem cell therapy, increase in government support for research and development activities and increase in healthcare expenditure.
Furthermore, increase in prevalence of diseases like cancer, and new product launches associated to the stem cell therapy are considerably contributing toward the stem cell therapy industry growth. However, limitations on use of embryonic stem cells due to ethical concerns and high cost of stem cell therapy are negatively impacting the stem cell therapy market growth. Conversely, surge in the applications of induced pluripotent stem cells in embryonic stem cell therapy offers the stem cell therapy market opportunity.
Impact of COVID-19 Pandemic on Stem Cell Therapy Market Size
Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. The situation of COVID-19 has varied outcome when related to vaccinations. There is an emerging gap in the economic recovery between high-income and low & middle income countries. After the pandemic severely disrupted global trade, the world is witnessing a robust rebound, which is helping with the recovery in the year 2021. Trade contributes to speeding up economic recovery from the pandemic by providing sustained foreign demand for exports and ensuring the availability of imported intermediate products and services. The COVID-19 pandemic affected the stem cell therapy industry in a negative way, like various other cell and gene therapies industries were affected. According to the data of National Institute of Health, the coronavirus (COVID-19) has caused significant disruption to the stem cells industry, which has historically faced substantial complexities in supply of materials, and manufacturing and logistics processes. The costs and reimbursements associated to the stem cell therapy was increased in the pandemic owing to the lockdown laws imposed during pandemic.
Stem Cell Therapy Market Segmentation
The stem cell therapy market is segmented into Cell Source, Application and Type. By cell source, the market is classified into adipose tissue-derived mesenchymal stem cells, bone marrow-derived mesenchymal stem cells, cord blood/embryonic stem cells, and other cell sources. By application, the market is classified into cancer, musculoskeletal disorders, wounds and injuries, cardiovascular diseases, gastrointestinal diseases, and other applications. By type, the market is classified into allogeneic transplants and autologous transplants. Furthermore, the allogeneic transplants are sub-classified as pediatric and adult. Also, the autologous transplants are sub-classified as pediatric and adult. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).
By Cell Source Segment Review
By cell source, adipose tissue-derived mesenchymal stem cells segment was the major revenue contributor in 2021 and is anticipated to continue this trend during the stem cell therapy market forecast period, due to increase in number of patients suffering from cancer. In addition, increasing target population, exposure to harmful radiation and increasing governmental initiatives also contributed toward the growth of the market. On the other side, bone marrow-derived mesenchymal stem cells segment is projected to exhibit the fastest market growth during the forecast period, owing to higher incidence of the chronic and fatal diseases such as musculoskeletal diseases, and rise in smoking of tobacco that includes passive smoking, which may lead to cancer.
By Application Segment Review
By application, cancer segment was the major revenue contributor in 2021, and is anticipated to continue this trend during the forecast period, due to increase in number of patients suffering from cardiovascular, musculoskeletal and gastrointestinal diseases. In addition, increase in R&D activities also contributed toward the growth of the market.
By Type Segment Review
By type, the autologous transplants segment is anticipated to grow with the largest stem cell therapy market share throughout the forecast period. This is attributed to the increase in the use of autologous stem cells, and availability of number of stem cell products. Recent advances in cellular technology have contributed to improve the understanding of various disease cells and their metabolism at molecular level, thus driving the need of stem cell therapies for the treatment.
By Region Review
North America accounted for the largest stem cell therapy market share of revenue in 2021 and is anticipated to maintain its dominance from 2021 to 2031, owing to presence of large patient population, strong presence of key players, ease of product availability, well developed healthcare infrastructure, favorable reimbursement policies in healthcare system, higher number of research, development, & innovation activities and higher adoption of advanced therapeutics. However, Asia-Pacific is expected to grow at the highest CAGR, owing to increase in number of cancer affected population and rise in number of applications of stem cell therapy.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the stem cell therapy market analysis from 2021 to 2031 to identify the prevailing stem cell therapy market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the stem cell therapy market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global stem cell therapy market trends, key players, market segments, application areas, and market growth strategies.
Stem cell therapy Market Report Highlights
| Aspects | Details |
 Market Size By 2031 | USD 928.6 million |
 Growth Rate | CAGR of 16.2% |
 Forecast period | 2021 - 2031 |
 Report Pages | 274 |
 By Cell Source |
|
 By Application |
|
 By Type |
|
 By Region |
|
 Key Market Players | Astellas Pharma Inc., U.S. Stem Cell, Inc., Takeda Pharmaceutical Company Ltd, Allele Biotechnology and Pharmaceuticals, Inc., NuVasive, Inc., Smith & Nephew plc, Orthofix Holdings, Inc., Fujifilm Holding Corporation, Novadip Biosciences, Mesoblast Ltd. |
Analyst Review
The utilization of stem cell therapy is expected to witness a significant rise owing to the increase in use of stem cell therapy in treatment of diseases such as autoimmune, inflammatory, neurological, orthopedic conditions and traumatic injuries with studies conducted on use for Crohn's disease, multiple sclerosis, lupus, COPD, Parkinson's disease and stroke recovery. Moreover, the prevalence of cancer in both developed and developing economies also aids in market growth.
North America accounted for the highest market share in 2021, due to availability of advance stem cell products, higher cancer awareness, and heavy expenditure by the government on healthcare, followed by Europe and Asia-Pacific. Asia-Pacific is expected to exhibit fastest market growth due to increase in incidence of cancer. Pharmaceutical companies have focused on expanding their presence in emerging economies, which is anticipated to drive the market growth
The estimated industry size of Stem cell therapy market is estimated to be $928.64 million in 2031.
The forecast period in the market report is from 2022 to 2031
The base year calculated in the stem cell therapy market report is 2021
Yes, the stem cell therapy market report provides PORTER Analysis.
The major companies profiled in the report include Allele Biotechnology and Pharmaceuticals, Inc., Astellas Pharma Inc, Fujifilm Holding Corporation (FUJIFILM Cellular Dynamics, Inc.), Mesoblast Ltd, Novadip Biosciences, NuVasive, Inc., Orthofix Holdings, Inc., Smith & Nephew plc, Takeda Pharmaceutical, and U.S. Stem Cell, Inc.
The increase in demand for stem cell therapy, increase in government support for R&D activities and increase in healthcare expenditure are the key trends of stem cell therapy market.
The leading application of stem cell therapy is that it promotes the tissue repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives.
North America is the largest regional market for Stem cell therapy.
Loading Table Of Content...
